MESA LABORATORIES INC /CO/ Cash Flow Statement
MLAB|15 years of annual SEC 10-K data (FY2011-FY2026)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
N/A
FY2026
Free Cash Flow
N/A
FY2026
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2026
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | $6.7M | -$2.0M | $3.3M | $930.0K | $1.9M | $3.3M | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | - | - | - | $17.7M | $33.8M | $25.1M | $17.7M | $13.0M | $9.4M | $9.5M | $8.7M | $7.2M | $5.7M | $1.8M | $2.2M |
| Operating Cash Flow | - | $42.8M | $46.8M | $37.1M | $28.0M | $39.2M | $37.1M | $27.0M | $30.6M | $25.7M | $17.3M | $16.9M | $10.8M | $8.9M | $12.5M |
| Capital Expenditures | - | $3.3M | $4.2M | $2.0M | $4.5M | $4.4M | $2.0M | $1.5M | $1.3M | $2.8M | - | - | - | - | - |
| Free Cash Flow | - | $39.6M | $42.6M | $35.1M | $23.4M | $34.8M | $35.1M | $25.5M | $29.3M | $22.9M | - | - | - | - | - |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | $22.0K | $105.0K | $597.0K |
| Dividends Paid | - | $3.5M | $3.5M | $3.2M | $3.4M | $3.3M | $3.2M | $2.7M | $2.5M | $2.4M | $2.4M | $2.3M | $2.2M | $1.5M | $1.6M |
| FCF Margin | - | 15.9% | 17.7% | 26.2% | 10.7% | 18.9% | 102.6% | 97.0% | 116.5% | 101.1% | - | - | - | - | - |